Yo-Ting Tsai
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
-
- Microbial Metabolism and Applications
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 2
- CAR-T cell therapy research 2
-
- Ubiquitin and proteasome pathways 2
- Heat shock proteins research 1
- Co-authors
- Han‐Shui Hsu (3 shared papers)Jeffrey Schlom (16 shared papers)Renee N. Donahue (16 shared papers)Shih‐Hwa Chiou (1 shared paper)Tien‐Wei Hsu (1 shared paper)Jiun‐Han Lin (1 shared paper)Kelly Su (1 shared paper)Shih‐Chieh Hung (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (5 papers)The Oncologist (3 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- United StatesTaiwanGermany
In The Last Decade
Yo-Ting Tsai
24 papers receiving 456 citations
Peers
Comparison fields: 5 of 60
- Oncology 153
- Biotechnology 41
- Immunology 84
- Cancer Research 42
- Molecular Biology 179
Countries citing papers authored by Yo-Ting Tsai
This map shows the geographic impact of Yo-Ting Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yo-Ting Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yo-Ting Tsai more than expected).
Fields of papers citing papers by Yo-Ting Tsai
This network shows the impact of papers produced by Yo-Ting Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yo-Ting Tsai. The network helps show where Yo-Ting Tsai may publish in the future.
Co-authors
The 25 scholars most cited alongside Yo-Ting Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 117 | |
| 2 | 2021 | 47 | |
| 3 | 2007 | 43 | |
| 4 | 2012 | 41 | |
| 5 | 2022 | 30 | |
| 6 | 2012 | 30 | |
| 7 | 2024 | 24 | |
| 8 | 2019 | 19 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 16 | |
| 11 | 2024 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2015 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2014 | 8 | |
| 17 | 2015 | 6 | |
| 18 | 2017 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2025 | 2 |
About Yo-Ting Tsai
Yo-Ting Tsai is a scholar working on Oncology, Molecular Biology, Neurology, Genetics and Pharmacology, having authored 25 papers that have together received 463 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Myasthenia Gravis and Thymoma (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers), Heat shock proteins research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (153 citations), Biotechnology (41 citations), Immunology (84 citations), Cancer Research (42 citations) and Molecular Biology (179 citations). Yo-Ting Tsai has collaborated with scholars based in United States, Taiwan and Germany. Frequent co-authors include Han‐Shui Hsu, Jeffrey Schlom, Renee N. Donahue, Shih‐Hwa Chiou, Tien‐Wei Hsu, Jiun‐Han Lin, Kelly Su, Shih‐Chieh Hung, Wen‐Chien Huang and James L. Gulley. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, The Oncologist, Journal of Clinical Oncology, Clinical Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.